Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumorsMing Yi, Kongming Wu, Mengke Niu et al.|Journal of Hematology & Oncology|2022Cited by 178
TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3Ming‐Ming Hu, Hong‐Bing Shu, Qing Yang et al.|Proceedings of the National Academy of Sciences|2014Cited by 151
Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunityFansen Meng, Pinglong Xu, Zhengyang Yu et al.|Molecular Cell|2021Cited by 128
Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patientsTong Liu, Hongquan Zhang, Cheng Liu et al.|Nature Communications|2022Cited by 109
Divergent Total Syntheses of (−)‐Daphnilongeranin B and (−)‐DaphenyllineXiao‐Ming Chen, Hongbin Zhai, Huifei Wang et al.|Angewandte Chemie International Edition|2017Cited by 98